Rayno Life Science Portfolios: AMGN, CLVS, ILMN, RGEN, TMO
Biotech and Healthcare Stocks Hit New Highs
The market roared back today with healthcare and biotech the strongest sectors. The Healthcare Select SPDR ETF (XLV) was up 2.21% to $73.40. This is a 52 week high. The Euro rallied 1% to 1.057 and that helped large cap companies with revenues outside the US. The XBI SPDR Biotech ETF (XBI) also hit a new high at $232. XLV should be added to portfolios underweighted in healthcare.
Amgen (AMGN) and Regeneron (REGN) soared on the potential of their PCSK9 inhibitor for cardiovascular disease.
Rayno Movers: Biopharmaceuticals
ABBV up 1.93%, AMGN up 5.69%, BIIB up 1.93%, CLVS up 4.87%, FBT up 2.35%, GILD up 1.7%, REGN up 5.2%, SGEN up 2.1%.
Rayno Movers : Diagnostics and Tools
CPHD up 3.15%, ILMN up 4.5%, QGEN up 2,54%, SQNM up 3.34%, TMO up 4.36%.
Disclosure: None.